|
|
Article: Gel could treat viral eye infection
- Article from:
- Ophthalmology Times
- Article date:
- February 15, 2007
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Feb 15, 2007. Provided by ProQuest LLC. (Hide copyright information)
|
Marketing deal
Tampa-Sirion Therapeutics Inc. has made an exclusive licensing agreement with Laboratoires Thea of France for U.S. rights to develop and market a topical ophthalmic gel containing ganciclovir for treating certain viral and superficial eye infections
Thea markets the gel in Europe as Virgan.
If it is approved, the topical ophthalmic antiviral gel would treat herpes simplex keratitis, the leading cause of ...